首页|PRDX1对脂多糖诱导的小胶质细胞炎症反应及细胞凋亡的作用机制

PRDX1对脂多糖诱导的小胶质细胞炎症反应及细胞凋亡的作用机制

扫码查看
目的 旨在探讨PRDX1对脂多糖诱导的小胶质细胞BV2神经炎症损伤的作用及潜在机制.方法 对于PRDX1 shRNA慢病毒感染实验,BV2细胞分为:对照组(BV2细胞进行正常培养),脂多糖处理组,NC shRNA慢病毒感染组(细胞经NC shRNA慢病毒感染48h后,用脂多糖处理24h组),PRDX1 shRNA慢病毒感染组(细胞经PRDX1 shRNA慢病毒感染48h后,用脂多糖处理24h组).对于TLR4过表达实验,在慢病毒感染实验的基础上增加TLR4过表达组(细胞经PRDX1 shR-NA慢病毒感染及TLR4过表达慢病毒感染48h后,用脂多糖处理24 h).RT-qPCR和Western blot分别用于检测mRNA和蛋白表达水平;采用ELISA法检测细胞培养上清液中炎症因子TNF-α和IL-6的分泌水平;MTT法检测细胞增殖活性;流式细胞术检测细胞凋亡率.结果 ELISA检测结果显示,与脂多糖处理的BV2细胞相比,PRDX1 shRNA慢病毒感染组TNF-α和IL-6的含量均显著减少(P<0.01).RT-qPCR结果表明,TNF-α和IL-6的mRNA表达水平和ELISA检测结果趋势一致.MTT法检测结果表明,与对照组相比,脂多糖处理组BV2细胞活力显著降低;而与脂多糖处理组相比,PRDX1 shRNA慢病毒感染组细胞活力明显升高.流式细胞术检测结果表明,与对照组相比,脂多糖处理组BV2细胞凋亡率明显增加,而与脂多糖处理组相比,PRDX1 shRNA慢病毒感染组细胞凋亡率明显减少.Western blot结果显示,与对照组细胞相比,脂多糖处理组BV2细胞中TLR4表达显著上调(P<0.05);而与脂多糖处理组BV2细胞相比,PRDX1 shRNA慢病毒感染显著抑制脂多糖诱导的TLR4表达(P<0.05).与PRDX1 shRNA慢病毒感染组相比,TLR4过表达组BV2细胞中炎症因子TNF-α及IL-6水平显著升高(P<0.05),细胞活力水平降低(P<0.05),且细胞凋亡水平显著升高(P<0.05).结论 沉默PRDX1明显促进脂多糖刺激BV2细胞活力,抑制脂多糖诱导的凋亡及炎症应答反应,其可能是通过正向调控TLR4来实现的.阐明PRDX1/TLR4信号轴在脂多糖诱导的BV2细胞损伤的重要作用,可能成为一个有前景的SCI潜在治疗靶点.
PRDX1 modulates LPS-triggered inflammatory response and cell apoptosis in microglial cells through TLR4 signaling axis
Objective To investigate the roles and potential mechanism of PRDX1 on inflammatory responses and apoptosis in lipopolysaccharide(LPS)-induced BV2 cells.Methods BV2 cells were divided into control group(BV2 cells were normally cul-tured),LPS treated group,NC shRNA lentivirus infection group(cells were infected with NC shRNA lentivirus for 48 hours and then treated with LPS for 24 hours),and PRDX1 shRNA lentivirus infec-tion group(cells were infected with PRDX1 shRNA lentivirus for 48 hours and then treated with LPS for 24 hours).For the TLR4 overex-pression experiment,a TLR4 overexpression group was added on the basis of the lentivirus infection experiment(cells were infected with PRDX1 shRNA lentivirus and TLR4 overexpression lentivirus for 48 hours,and then treated with LPS for 24 hours).RT-qPCR and Western blot were adopted to estimate the mRNA and protein expres-sion,respectively.The evaluation of cell viability was executed by MTT assay.Cell apoptosis was appraised by flow cytometry.ELISA assays were implemented for the measurement of the release of inflammatory factors such as TNF-α and IL-6.Results Test results of ELISA showed that compared with BV2 cells treated with LPS,the levels of TNF-α and IL-6 in the PRDX1 shRNA lentivirus infec-tion group were significantly reduced(P<0.01).The RT qPCR results showed that the mRNA expression levels of TNF-α and IL-6 were consistent with the trend of ELISA test results.The MTT assay results showed that compared with the control group,the viability of BV2 cells in the LPS treatment group was significantly reduced;Compared with the LPS treatment group,the PRDX1 shRNA lenti-virus infection group showed a significant increase in cell viability.The results of flow cytometry analysis showed that compared with the control group,the apoptosis rate of BV2 cells in the LPS treatment group was significantly increased,while compared with the LPS treatment group,the apoptosis rate of PRDX1 shRNA lentivirus infection group was significantly reduced.Western blot results showed that compared with the control group,the expression of TLR4 was significantly upregulated in BV2 cells treated with LPS(P<0.05);Compared with BV2 cells treated with LPS,PRDX1 shRNA lentivirus infection significantly inhibited TLR4 expression induced by LPS(P<0.05).Compared with the PRDX1 shRNA lentivirus infection group,the TLR4 overexpression group showed significantly in-creased levels of inflammatory factors TNF-α and IL-6 in BV2 cells(P<0.05),decreased cell viability levels(P<0.05),and signifi-cantly increased levels of cell apoptosis(P<0.05).Conclusion Perturbation of PRDX1 visibly promoted cell viability,and restrict-ed inflammatory response and cell apoptosis process in LPS-evoked BV2 cells via positive regulating TLR4 expression.These findings elucidated the novel role of PRDX1/TLR4 axis in regulating SCI,and may be served as a promising therapeutic target for SCI treatment.

PRDX1/TLR4 axisinflammatory responseapoptosisspinal cord injury

陈旭狮、姚仕奋、蔡宏华、罗思东、王业杨

展开 >

516008 惠州,惠州市中心人民医院骨科二区

510000 广州,广东省第二人民医院骨科中心

PRDX1/TLR4轴 炎症应答 凋亡 脊髓损伤

广东省中医药局科研课题面上项目惠州市科技计划项目

20221474210418234575032

2024

医学研究生学报
南京军区南京总医院

医学研究生学报

CSTPCD北大核心
影响因子:1.652
ISSN:1008-8199
年,卷(期):2024.37(5)